Skip to main content
SpringerLink
Log in

Pathophysiology and Pharmacology of Erythropoietin

  • Conference proceedings
  • © 1992

Overview

Editors:
  1. Horst Pagel

    1. Institut für Physiologie, Medizinische Universität zu Lübeck, Lübeck 1, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Christoph Weiss

    1. Institut für Physiologie, Medizinische Universität zu Lübeck, Lübeck 1, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Wolfgang Jelkmann

    1. Physiologisches Institut I, Rheinische Friedrich-Wilhelms-Universität, Bonn 1, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (40 papers)

  1. Erythropoietin Replacement in Renal Failure

    1. Iron Metabolism Under Treatment of Renal Anemia with Recombinant Human Erythropoietin

      • P. Grützmacher, P. Roth, J. Vlachojannis, T. Tsobanelis, E. Werner
      Pages 147-152

    2. Erythropoietin Treatment in Children with Renal Anemia

      • D. E. Müller-Wiefel, O. Amon, K. Schärer, K. Daniel, A. Leder
      Pages 153-163

    3. Bone Marrow Erythroid Precursor Cytoplasmic Ca2+ and 1,25-Dihydroxyvitamin D3 Regulate the Response to Human Recombinant Erythropoietin in Uremia: In Vitro and In Vivo Studies

      • S. Carozzi, M. G. Nasini, A. Cantaluppi, M. Salit, S. Lamperi
      Pages 165-169

    4. Dyserythropoietic Abnormalities in Hemodialysis Patients on Long-Term Therapy with Human Recombinant Erythropoietin

      • S. Lamperi, S. Carozzi, M. G. Nasini, A. Cantaluppi, M. Salit
      Pages 171-176

    5. Cardiological Findings in Patients with End-Stage Renal Failure Under Treatment with Erythropoietin

      • G. Schütterle, W. Kramer, R. Schäfer, J. Kaufmann, V. Wizemann
      Pages 177-180

    6. Long-Term Treatment with Recombinant Human Erythropoietin in Haemodialysis Patients: Effects on Left Ventricular Performance

      • S. Casati, G. C. Ambroso, C. Ponticelli, A. Pierini, R. Mangiarotti, C. Pini
      Pages 181-188

    7. Retinal Hypoxia and Anemia in Chronic Renal Failure: Effect of Erythropoietin

      • C. Costagliola, M. Rinaldi, P. Sorice, A. Di Benedetto
      Pages 189-192

    8. Experience with Subcutaneous Versus Intravenous Administration of Erythropoietin in Haemodialysis Patients

      • K. W. Dreyling, K. Ehlen, P. Schollmeyer, W. H. Hörl
      Pages 193-203

    9. Pharmacodynamic Aspects of Recombinant Human Erythropoietin — Long-Term Results in Patients with Hemodialysis Treatment

      • H. W. F. Wilms, J. Berger, U. Gattig, G. Warnecke, J. Kloppstech, T. Döll et al.
      Pages 205-212

    10. Comparison of Three Routes of Administration of Recombinant Human Erythropoietin Expressed in C-127 Mouse Cells

      • T. Brune, H. Heinrichs, G. Reiner, R. Zerban, J.-U. Pauly, L. Fontaine et al.
      Pages 213-218

    11. Peritoneal Permeability in Continuous Ambulatory Peritoneal Dialysis After the Correction of Anemia by Erythropoietin

      • C. Castelnovo, A. De Vecchi, A. Scalamogna, S. Casati
      Pages 219-222

  2. Primary Hemopoietic Disorders and Chemotheraphy

    1. Front Matter

      Pages 223-223
      Download chapter PDF

    2. Serum Erythropoietin Levels in Aplastic Anemia Determined by ELISA

      • H. Schrezenmeier, G. Noé, I. N. Rich, A. Raghavachar
      Pages 225-231

    3. Serum Erythropoietin in Myelodysplastic Syndromes

      • A. Grossi, D. Rafanelli, A. M. Vannucchi, G. Longo, P. Bacci, A. Del Genovese et al.
      Pages 233-237

    4. Antigenic Characteristics of Erythropoietin-Dependent and -Independent Erythroid Progenitors in Chronic Myeloproliferative Disorders Defined by Monoclonal Antibodies

      • T. Robak
      Pages 239-244

    5. Chemotherapy and Erythropoietin Production

      • C. Pohl, A. Moter, D. Hasenclever, E. M. Woll, M. Löffler, C. A. Baldamus
      Pages 245-251

    6. Production of Erythropoietin During and After Thiamphenicol Treatment Occurs Independently of Peripheral Blood Cell Numbers

      • W. Nijhof, H. Goris, H. Hartsuiker
      Pages 253-259

  3. Application of Recombinant Erythropoietin in Non-Renal Anemia

    1. Front Matter

      Pages 261-261
      Download chapter PDF

    2. Effects of Inflammatory Cytokines on the Production of Erythropoietin

      • W. Jelkmann, J. Fandrey, H. Pagel
      Pages 263-269

    3. The Use of Recombinant Human Erythropoietin in the Treatment of the Anemia of Chronic Disorders

      • J. P. Kaltwasser, F. Praeve, R. Wigand, T. Brune
      Pages 271-278
Back to top

Keywords

Editors and Affiliations

  • Institut für Physiologie, Medizinische Universität zu Lübeck, Lübeck 1, Germany

    Horst Pagel, Christoph Weiss

  • Physiologisches Institut I, Rheinische Friedrich-Wilhelms-Universität, Bonn 1, Germany

    Wolfgang Jelkmann

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation